Gedeon Richter
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe
Phil Taylor
biosimilar, Eli Lilly, Gedeon Richter, osteoporosis
0 Comment
X
Lilly faces biosimilar rivals to osteoporosis drug Forsteo in Europe
https://pharmaphorum.com/news/lilly-faces-biosimilar-rivals-to-osteoporosis-drug-forsteo-in-europe/
Allergan and Gedeon Richter set to expand use of bipolar drug
Richard Staines
Allergan, bipolar disorder, depression, Gedeon Richter
0 Comment
Companies want Vraylar as option bipolar depression
X
Allergan and Gedeon Richter set to expand use of bipolar drug
https://pharmaphorum.com/news/allergangedeon-richter-aim-expand-use-bipolar-drug/
Drug price controversies hit pharma’s reputation
Richard Staines
Gedeon Richter, Grifols, patient group, pricing, Shire, Valeant
0 Comment
Patient groups slam pharma over drug costs in latest survey.
X
Drug price controversies hit pharma’s reputation
https://pharmaphorum.com/news/drug-price-pharma-reputation/
News/ Sales and Marketing/ UK & Europe
Allergan/Gedeon Richter’s uterine fibroids drug succeeds in Phase 3
X
Allergan/Gedeon Richter’s uterine fibroids drug succeeds in Phase 3
https://pharmaphorum.com/news/allergan-gedeon-richters-uterine-fibroids-drug-succeeds-in-phase-3/